obesity treatment market – The Milli Chronicle

Monday, February 2, 2026

Latest:

Factual Version of a Story

Asia Latest News

NewsDesk Milli Chronicle January 24, 2026 affordable weight loss drugs, Alkem semaglutide approval, diabetes semaglutide India, generic GLP-1 drugs, generic Ozempic India, generic Wegovy India, healthcare affordability India, Indian drugmakers obesity race, Indian pharma industry growth, Indian pharma semaglutide, obesity drugs India, obesity medicine competition, obesity treatment market, pharma market India 2026, pharmaceutical approvals India, semaglutide generic approval, Sun Pharma obesity drug, weight loss drug demand, weight loss medicine India, Zydus weight loss drug

Indian Drugmakers Enter Obesity Treatment Market With Generic Wegovy Approval

Mumbai – India’s pharmaceutical industry is set to intensify competition in the booming obesity and diabetes drug market after regulators

Featured News World

NewsDesk Milli Chronicle November 13, 2025November 13, 2025 digital health, drug partnership denial, drug safety, Eli Lilly, Eli Lilly news, fake weight-loss drugs, GLP-1 treatments, healthcare transparency, Mangoceuticals, Mounjaro, Novo Nordisk, Novo Nordisk news, obesity drug market, obesity drugs, obesity treatment market, online pharmacy safety, pharmaceutical industry, telehealth company, telemedicine, Wegovy, weight loss medication, Zepbound

Novo Nordisk and Eli Lilly Reject Claims of Partnership with Mangoceuticals on Obesity Drugs

Novo Nordisk and Eli Lilly clarify that they have no collaboration or special arrangement with telehealth firm Mangoceuticals, following misleading